Results 41 to 50 of about 874,362 (147)

Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine [PDF]

open access: yes, 2013
Streptococcus pneumoniae causes invasive infections, primarily at the extremes of life. A seven-valent conjugate vaccine (PCV7) is used to protect against invasive pneumococcal disease in children.
Nicholas J Loman   +53 more
core   +1 more source

Modern Approaches to Vaccinal Prevention of a Pneumococcal Infection in Adults Patients with Diabetes Mellitus (Literature Review)

open access: yesЭпидемиология и вакцинопрофилактика, 2018
At present, pneumococcal infections remain a major cause of morbidity and mortality around the world, being one of the ten leading causes of death worldwide.
J. A. Paramonova   +4 more
doaj   +1 more source

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. [PDF]

open access: yes, 2011
BACKGROUND: Several decision support tools have been developed to aid policymaking regarding the adoption of pneumococcal conjugate vaccine (PCV) into national pediatric immunization programs.
A.M. Henao   +31 more
core   +2 more sources

Continued control of pneumococcal disease in the UK - the impact of vaccination

open access: yes, 2011
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mortality in the developed and developing world. Pneumococcal conjugate vaccines were first introduced for routine use in the USA in 2000, although the seven-
Gladstone, R.A.   +11 more
core   +1 more source

Estimating the transmission parameters of pneumococcal carriage in households [PDF]

open access: yes, 2004
This paper analyses Streptococcus pneumoniae transmission dynamics in households using longitudinal data on pneumococcal (Pnc) carriage in the United Kingdom. Ten consecutive swabs were taken at 4-week intervals from all members of 121 households.
Medley, Graham   +5 more
core   +1 more source

PNEUMOCOCCAL INFECTIONS AS MODERN THREAT TO HEALTH OF EARLY AGE CHILDREN: VACCINATION PROSPECTS

open access: yesПедиатрическая фармакология, 2009
Wide spread of pneumococcal carriage, resistance to human organism defenses and ease of developing antibiotic resistance makes pneumococcus an extremely significant pathogen.
E.F. Lukushkina
doaj   +2 more sources

Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia.

open access: yesPLoS ONE, 2014
BackgroundEven though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown.Methods and findingsThis study was performed to evaluate the impact of ...
Joon Young Song   +3 more
doaj   +1 more source

The Saudi Thoracic Society pneumococcal vaccination guidelines-2016

open access: yesAnnals of Thoracic Medicine, 2016
Streptococcus pneumoniae (pneumococcus) is the leading cause of morbidity and mortality worldwide. Saudi Arabia is a host to millions of pilgrims who travel annually from all over the world for Umrah and the Hajj pilgrimages and are at risk of developing
N S Alharbi   +7 more
doaj   +1 more source

Non-specific effects of pneumococcal conjugate vaccines: clinical significance and molecular mechanisms

open access: yesЖурнал инфектологии
Pneumococcal conjugate vaccines (PCVs) are widely used to prevent infections caused by Streptococcus pneumoniae, but evidence shows that they also exert clinically relevant nonspecific effects. This review summarizes current data on the impact of PCVs on
A. U. Mirzova   +2 more
doaj   +1 more source

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study

open access: yesNature Communications, 2023
Vaccination against invasive pneumococcal disease is recommended for older adults but the optimal age group to target has not been determined and may vary by epidemiological setting.
Deus Thindwa   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy